These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30305676)

  • 1. Trypsinogen isoforms in the ferret pancreas.
    Hegyi E; Sahin-Tóth M
    Sci Rep; 2018 Oct; 8(1):15094. PubMed ID: 30305676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The guinea pig pancreas secretes a single trypsinogen isoform, which is defective in autoactivation.
    Ozsvári B; Hegyi P; Sahin-Tóth M
    Pancreas; 2008 Aug; 37(2):182-8. PubMed ID: 18665081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.
    Németh BC; Wartmann T; Halangk W; Sahin-Tóth M
    J Biol Chem; 2013 Aug; 288(33):24049-62. PubMed ID: 23814066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
    Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
    Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases.
    Kukor Z; Tóth M; Sahin-Tóth M
    Eur J Biochem; 2003 May; 270(9):2047-58. PubMed ID: 12709065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogen.
    Simon P; Weiss FU; Sahin-Toth M; Parry M; Nayler O; Lenfers B; Schnekenburger J; Mayerle J; Domschke W; Lerch MM
    J Biol Chem; 2002 Feb; 277(7):5404-10. PubMed ID: 11719509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.
    Jancsó Z; Sahin-Tóth M
    J Biol Chem; 2016 Jun; 291(25):12897-905. PubMed ID: 27129265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis.
    Szilágyi L; Kénesi E; Katona G; Kaslik G; Juhász G; Gráf L
    J Biol Chem; 2001 Jul; 276(27):24574-80. PubMed ID: 11312265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis.
    Sahin-Tóth M
    J Biol Chem; 2000 Jul; 275(30):22750-5. PubMed ID: 10801865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary pancreatitis-associated mutation asn(21) --> ile stabilizes rat trypsinogen in vitro.
    Sahin-Tóth M
    J Biol Chem; 1999 Oct; 274(42):29699-704. PubMed ID: 10514442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.
    Szabó A; Sahin-Tóth M
    J Biol Chem; 2012 Jun; 287(24):20701-10. PubMed ID: 22539344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis.
    Kukor Z; Mayerle J; Krüger B; Tóth M; Steed PM; Halangk W; Lerch MM; Sahin-Tóth M
    J Biol Chem; 2002 Jun; 277(24):21389-96. PubMed ID: 11932257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tetra-aspartate motif in the activation peptide of human cationic trypsinogen is essential for autoactivation control but not for enteropeptidase recognition.
    Nemoda Z; Sahin-Tóth M
    J Biol Chem; 2005 Aug; 280(33):29645-52. PubMed ID: 15970597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen.
    Sahin-Tóth M; Tóth M
    Biochem Biophys Res Commun; 2000 Nov; 278(2):286-9. PubMed ID: 11097832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathobiochemistry of hereditary pancreatitis: studies on recombinant human cationic trypsinogen.
    Sahin-Tóth M
    Pancreatology; 2001; 1(5):461-5. PubMed ID: 12120225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.
    Geisz A; Hegyi P; Sahin-Tóth M
    FEBS J; 2013 Jun; 280(12):2888-99. PubMed ID: 23601753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and functional analysis of rat P23, a gut hormone-inducible isoform of trypsin, reveals its resistance to proteinaceous trypsin inhibitors.
    Fukuoka S; Nyaruhucha CM
    Biochim Biophys Acta; 2002 Nov; 1588(2):106-12. PubMed ID: 12385773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible lysosomal activation of pancreatic zymogens. Activation of both human trypsinogens by cathepsin B and spontaneous acid. Activation of human trypsinogen 1.
    Figarella C; Miszczuk-Jamska B; Barrett AJ
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():293-8. PubMed ID: 3202969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The two human trypsinogens. Evidence of complex formation with basic pancreatic trypsin inhibitor-proteolytic activity.
    Colomb E; Figarella C; Guy O
    Biochim Biophys Acta; 1979 Oct; 570(2):397-405. PubMed ID: 40607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a cDNA encoding rat cationic trypsinogen.
    Fletcher TS; Alhadeff M; Craik CS; Largman C
    Biochemistry; 1987 Jun; 26(11):3081-6. PubMed ID: 3607011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.